Award Profile:
This award was established in 2015 to recognize individuals for outstanding contributions in patient-oriented clinical outcomes research that has significant impact on diabetes prevention and treatment.
Criteria for Selection (candidates can be peer or self-nominated):
- The nominee’s research must be patient-oriented, including clinical trials and outcomes research involving human subjects.
- The nominee is well-known nationally or internationally for exceptional clinical research knowledge and expertise.
- The nominee has outstanding track record of sharing their expertise with other health care professionals as documented by presentations and/or authorship of books/articles/reference materials.
- The nominee can represent any type of diabetes clinical professional.
- The nominee is a current member of the Professional Section of the American Diabetes Association® (ADA).
- Both U.S. and non-U.S. residents are eligible for award.
- Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.
Lecture/Publication:
- There is no lecture associated with this award.
Honorarium/Travel/Registration:
- The recipient receives a $3,000 honorarium.
- The award includes two round-trip coach airfares and hotel accommodations for the duration of the Scientific Sessions.
- The award includes complimentary registration to the 85th Scientific Sessions in Chicago, IL, taking place June 20–23, 2025.
2025 Nomination/Submission Process:
- Nominations must be submitted using the new electronic nomination form. All submissions must be received on or before 8:00 p.m. ET on September 20, 2024.
Nominations are accepted from any ADA professional member.
All Clinical Research in Diabetes Awards nominations must have the following documents uploaded as one PDF file:
- A letter of nomination/support, whether peer or self-nominated, must be no more than 400 words and signed by no more than three individuals.
- The nomination letter/support should address criteria for selection (above), the most significant clinical research accomplishments of the nominee, and the impact of these accomplishments on clinical practice/patient care and outcomes.
The nominee’s CV with career and publication highlights.
Questions? Email Gedeon Topacio, program manager of research & scientific programs, at gtopacio@diabetes.org.
Selection:
The recipient is chosen by the National Scientific & Health Care Achievement Awards Committee and approved by the ADA’s Executive Committee in February 2025.